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Abstract 
Environmental contaminant exposure can pose significant risks to human health. 
Therefore, evaluating the impact of this exposure is of great importance; however, it is 
often difficult because both the molecular mechanism of disease and the mode of action 
of the contaminants are complex. We used network biology techniques to quantitatively 
assess the impact of environmental contaminants on the human interactome and 
diseases with a particular focus on seven major contaminant categories: persistent 
organic pollutants (POPs), dioxins, polycyclic aromatic hydrocarbons (PAHs), 
pesticides, perfluorochemicals (PFCs), metals,andpharmaceutical and personal care 
products (PPCPs). We integrated publicly available data on toxicogenomics, the 
diseasome, protein–protein interactions (PPIs), and gene essentiality and found that a 
few contaminants were targeted to many genes, and a few genes were targeted by many 
contaminants. The contaminant targets were hub proteins in the human PPI network, 
whereas the target proteins in most categories did not contain abundant essential 
proteins. Generally, contaminant targets and disease-associated proteins were closely 
associated with the PPI network, and the closeness of the associations depended on the 
disease type and chemical category. Network biology techniques were used to identify 
environmental contaminants with broad effects on the human interactome and 
contaminant-sensitive biomarkers. Moreover, this method enabled us to quantify the 
relationship between environmental contaminants and human diseases, which was 
supported by epidemiological and experimental evidence. These methods and findings 
have facilitated the elucidation of the complex relationship between environmental 
exposure and adverse health outcomes. 
Keywords: environmental contaminants; human interactome; network biology; adverse 
outcomes 
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polychlorinated biphenyls; PCDD, polychlorinated dibenzo-p-dioxins; PCDF, 
polychlorinated dibenzofurans; PFCs, perfluorochemicals; PFOA, perfluorooctanoic 
acid; PFOS, perfluorooctanesulfonic acid; PFOSF, perfluorooctanesulfonyl fluoride; 
POPs, persistent organic pollutants; PPAR, peroxisome proliferator-activated receptor; 
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necrosis factor; US EPA, US Environmental Protection Agency.  
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1. Introduction 
Humans are exposed to a range of ubiquitous environmental contaminants, which poses 
a major risk to human health (Gross and Birnbaum, 2017). Studies conducted over the 
last few decades have revealed the relationships between environmental contaminants, 
genes, and diseases. For example, dioxins and polycyclic aromatic hydrocarbons 
(PAHs) cause several types of cancer (Kim et al., 2013; Tavakoly Sany et al., 2015); 
metallic elements damage multiple organs and cause ailments such as pneumonia, 
depression, skin lesions, and cancer (Tchounwou et al., 2012); and the persistent 
exposure to pesticides results in endocrine disruption and polyneuropathy in humans 
(Hernández et al., 2013). The data on the association between contaminants, genes, and 
adverse outcomes obtained from previous studies have been curated and deposited in 
the Comparative Toxicogenomics Database (CTD) (Davis et al., 2017).  
The quantification of the association between exposure to individual chemicals and 
human health outcomes could help guide public health efforts by enabling the 
intervention in the use of high-risk agents (Braun et al., 2016). However, it is often 
difficult to evaluate the involvement of contaminants in human disease development 
because their effects are complex and often indirect (Briggs, 2003). The molecular 
mechanisms of action of contaminants in inducing human diseases are still poorly 
understood in the context of the human interactome. From this perspective, network 
science (Barabási, 2013) and network biology (Barabási and Oltvai, 2004) are useful 
because networks describe the relationships among elements (nodes) and provide 
simple and powerful tools for the description and analysis of complicated data sets. In 
particular, recent computational approaches of network science have successfully used 
large-scale data on drug-disease associations and disease-gene associations to better 
understand drug-disease interactions (Goh et al., 2007; Reyes-Palomares et al., 2013; 
Yıldırım et al., 2007). Yıldırım et al. (2007) constructed drug-target networks that 
described the relationship between approved/experimental drugs and their target 
proteins, and systematically evaluated the effects of drugs on the human interactome 
and diseases using data of essential genes and protein–protein interactions (PPIs). The 
network-based approach has also been used to obtain comprehensive information on the 
relationship between contaminants and biological functions. Darabos et al. (2016) 
investigated the relationships between environmental pollutants and biological 
pathways to identify candidate biological pathways that might be disrupted by exposure 
to environmental contaminants. However, the human disease-inducing effects of 
environmental pollutant are still not fully characterized. 
In this study, we quantitatively evaluated the impact of environmental contaminants on 
the human interactome and diseases using techniques based on network biology and 
inspired by Yıldırım et al. (2007). We collected datasets on chemical-gene, gene-
disease, and chemical-disease associations and then manually classified the chemical 
compounds into the following seven categories based on the major chemical 
contaminants, persistent organic pollutants (POPs), dioxins, PAHs, pesticides, 
perfluorochemicals (PFCs), metals, and pharmaceutical and personal care products 
(PPCPs). Moreover, we quantified the relationships between chemicals and disease-
associated genes in a human PPI network using complex network analysis. In particular, 
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we demonstrated the different effects of the chemicals in each category on human 
disease development. 
2. Materials and Methods 
Dataset of chemical-gene interactions 
We obtained the dataset of chemical-gene interactions (chemical targets) from the CTD 
database (ctdbase.org) (Davis et al., 2017) on July 06, 2017. The dataset contained 
12,373 chemical entries. The chemical-target network was represented as a bipartite 
network in which an edge was drawn between a gene and the chemical compounds that 
targeted it. 
Classification of chemical compounds 
The chemicals included in this study were selected based on the availability of curated 
data linked to genes and chemicals, the seriousness of known health effects, and 
scientific data that suggested exposure risks in humans. We extracted 535 substances 
that targeted human proteins and classified the substances into the following seven 
chemical contaminant categories: POPs, dioxins, PAHs, pesticides, PFCs, metals, and 
PPCPs, as well as US Food and Drug Administration (FDA)-approved drugs. These 
categories were defined based on the following criteria. However, it should be noted 
that a chemical compound could be classified into multiple categories.  
POPs: The POP category was defined based on Annex A of the Stockholm Convention 
on Persistent Organic Pollutants (UNEP, 2009) and includes organochlorine pesticides 
(e.g. dieldrin, dichlorodiphenyldichloroethylene (DDE), 
dichlorodiphenyltrichloroethane (DDT), endosulfan, heptachlor, hexachlorobenzene 
(HCB), and lindane), polybrominated biphenyls (PBBs), polychlorinated biphenyls 
(PCBs), and polychlorinated dibenzo-p-dioxins and dibenzofuranes (PCDD/Fs) that are 
commonly known as dioxins, polybrominated diphenyl ethers (PBDE) (tetra-, penta-, 
hexa-, and hepta-brominated diphenyl ethers), perfluoroalkyl substances (PFOS, its 
salts, and perfluorooctanesulfonyl fluoride [PFOSF]). Of these chemicals, we extracted 
77 available substances from the CTD database. 
Dioxins: According to the US Environmental Protection Agency (US EPA) (US EPA, 
2004), we categorized the following chemicals as dioxins and dioxin-like compounds: 
10 PCDFs, 7 PCDDs, and 12 PCBs. In this study, 12 dioxin-like compounds including 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) were available in the CTD database and 
were classified into the dioxin category. 
PAHs: PAHs are a large category of chemicals comprising two or more fused aromatic 
rings. We focused on PAHs in the priority-pollutant lists of the US EPA and the 
European Food Safety Authority (EFSA) (EFSA, 2008; US EPA, 2014). Eighteen 
substances including benzo[a]pyrene (BaP) were available in the CTD database and 
were further analyzed. 
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Pesticides: This category was based on the Updated Tables, January 2017, of the Fourth 
National Report on Human Exposure to Environmental Chemicals, 2009 (CDC., 2017); 
in particular, we considered the substances assigned to the following categories as 
pesticides: insect repellents and metabolites, carbamate pesticide metabolites, 
organochlorine pesticide metabolites, organophosphorus insecticides, pyrethroid 
metabolites, and organochlorine pesticides and metabolites. Finally, 18 substances 
including DDE and DDT were available in the CTD database and were included in our 
analysis. 
PFCs: PFCs were defined as chemical substances assigned to the perfluoroalkyl 
polyfluoroalkyl categories of the Fourth Report (CDC., 2017). Eight available 
substances including perfluorooctanoic acid (PFOA) and PFOS were identified in the 
CTD database and were included in our analysis. 
Metals: The substances assigned to the metal and metalloid category in the Fourth 
Report (CDC., 2017) and the heavy metal category in the CTD database (Davis et al., 
2017) were included in this category. A total of 74 substances such as arsenic (As), 
copper (Cu), and zinc (Zn) from the CTD database were analyzed in this study. 
PPCPs: Despite the absence of a consensus on the definition of PPCPs, in this study 
they were defined as substances assigned as personal care and consumer product 
chemicals and metabolites in the CDC Updated Tables of the Fourth Report (CDC., 
2017) and several previous studies (Batt et al., 2016; Howard and Muir, 2011; Tanoue 
et al., 2015). We analyzed 18 substances that included acetaminophen and ibuprofen, 
which were available in the CTD database. 
FDA-approved drugs: For comparison with a previous study (Yıldırım et al., 2007), we 
also considered approved drugs. We identified FDA-approved drugs from the 
DrugBank database (drugbank.ca) (Law et al., 2014) on May 1, 2017. We included 331 
substances such as fluorouracil that were available in the CTD database in the analysis. 
Gene-disease and chemical-disease association datasets  
We obtained datasets of gene-disease and chemical-disease associations from the CTD 
database (Davis et al., 2017) on July 06, 2017. The dataset of gene-disease associations 
consisted of 54,876,955 associations between 5,792 diseases (including disorders) and 
42,710 disease-associated genes. The dataset of chemical-disease associations contained 
5,080,629 associations between 5,814 diseases and 14,978 disease-associated 
chemicals. We extracted only the associations supported by therapeutic or 
marker/mechanism in the Direct Evidence field as direct evidence. Finally, the datasets 
of the gene-disease and chemical-disease associations consisted of 26,742 associations 
between 4,400 diseases and 7,352 disease-associated genes, and 93,464 associations 
between 3,152 diseases and 9,300 disease-associated chemicals, respectively. 
Human protein–protein interaction network 
We obtained physiological human PPI data from a previous study (Yıldırım et al., 
2007). We used datasets of PPIs from three high-quality systematic yeast two-hybrid 
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experiments and the published literature using manual curation (Goh et al., 2007; 
Rolland et al., 2014; Rual et al., 2005; Stelzl et al., 2005). We integrated the datasets to 
obtain the PPI data that consisted of 37,946 non-self-interacting and non-redundant 
interactions between 10,367 proteins (Table S1). The PPI network was presented as a 
binary unipartite network in which nodes and edges represented the proteins and 
physiological PPIs, respectively. We mapped the chemical target and disease-associated 
proteins onto the PPI network. 
Essential human genes 
To compare the node degree in essential genes and chemical target proteins in the 
human PPI and determine whether the chemical target proteins are enriched in essential 
genes, we obtained a dataset of essential genes identified using the clustered regularly 
interspaced short palindromic repeats (CRISPR) system from a previous study (Blomen 
et al., 2015). The degree of differences was compared using the Wilcoxon rank-sum 
test, and the enrichments were statistically evaluated using Fisher’s exact test. 
Evaluating effects of chemical compounds on human diseases using PPI 
network 
According to the methods of a previous study (Yıldırım et al., 2007), we evaluated the 
impact of chemicals on human diseases using a PPI network. The impact was evaluated 
based on the distance (shortest path length) between the chemical target and disease-
associated proteins in the PPI network compared to random controls. The disease-
associated genes were classified into 34 disease categories according to the MEDIC-
Slim classification terms of the CTD database (Davis et al., 2013). Italic font was used 
to indicate the MEDIC-Slim categories to distinguish the terms from disease names. In 
this study, we only focused on 14 categories (cancer, cardiovascular disease, 
congenital abnormality, digestive system disease, endocrine system disease, immune 
system disease, mental disorder, metabolic disease, musculoskeletal disease, nervous 
system disease, pregnancy complication, respiratory tract disease, signs and symptoms, 
and skin disease) that had sample sizes sufficient for statistical tests. First, we calculated 
the minimum value (Dreal) of the distance between the chemical targets and the disease-
associated proteins. Then, we calculated the distribution of the minimum distance for 
each disease in the category. To generate the controls, we randomly selected proteins 
with the same number of chemical target proteins from the PPI network 500 times to 
control the chemical targets. We kept the disease-associated proteins constant and 
calculated the minimum values (Drand) for the distance between randomly selected 
targets and disease-associated proteins. The effect of chemicals on human disease was 
based on the difference between the actual data and the random controls. We evaluated 
the difference between the distribution of Dreal and Drand using the Kolmogorov-Smirnov 
(KS) test for each chemical category. Moreover, the differences in the mean values 
between Dreal and Drand were evaluated using Welch’s two-sample t-test, which was 
quantified using the log2 ratio, defined as log$(〈'()*+〉/〈'(*./〉). Furthermore, 〈1〉 
indicates the mean value of x. A smaller log2 ratio was indicative of a more direct effect 
of the chemicals on the disease; a log2 ratio ≥ 0 indicated an indirect effect on the 
disease. When the log2 ratio was < 0 and the mean values between Dreal and Drand were 
not significantly different, it was also considered to indicate an indirect effect. 
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Statistical analyses and network analyses 
The statistical and network analyses were performed using the R packages stats (version 
3.3.2), exactRankTests (version 0.8.29), and igraph (version 1.1.2) in R software 
(version 3.3.2; www.r-project.org). The node degree (i.e., the number of edges per 
node) was calculated using the degree function in the igraph package to evaluate the 
characteristics of each node. In this context, we also calculated the following nodal 
measures (Freeman, 1978; Takemoto and Oosawa, 2012): closeness centrality, 
betweenness centrality, and clustering coefficients using closeness, betweenness, and 
transitivity functions in the igraph package, respectively. The closeness centrality is 
based on the shortest path length between nodes. A node with a large closeness 
centrality indicates that the average path length between that and the other nodes is 
relatively short. The betweenness centrality describes a walker’s movement from one 
node to another via the shortest path; therefore, nodes with a large number of visits by 
the walker shows high betweenness centrality. The clustering coefficient of a node 
characterizes the edge density among neighbors of the node. The shortest path length of 
a given node pair was obtained using the distances function in the igraph package. The 
differences in the median degree were evaluated based on the Wilcoxon rank-sum test; 
specifically, the wilcox.exact function in the exactRankTests library. Fisher’s exact test, 
the KS test, and Welch’s two-sample t-test were computed using the functions 
fisher.test, ks.test, and t.test in the stats library, respectively. 
3. Results 
Chemical-target network 
The extracted CTD dataset included 12,304 interactions for 3,326 genes and 535 
chemical compounds including 77 POPs, 12 Dioxins, 18 PAHs, 18 Pesticides, 8 PFCs, 
74 Metals, 18 PPCPs, and 331 FDA-approved drugs (Table S2), which were used to 
construct the chemical-target (i.e., chemical-gene interaction) network (Fig. 1). To 
characterize the connectivity tendencies, the frequency node degree distributions in the 
chemical-target networks were investigated. In bipartite networks, we considered the 
distributions of chemical and target nodes. The node degrees of a chemical compound 
and gene (chemical target) correspond to the number of genes targeted by the chemical 
(nc) and the number of chemicals targeting to the gene (ng), respectively. The frequency 
distributions of nc and ng were fat-tailed (Fig. 2), which indicated that most chemicals 
targeted a few genes; however, a few chemicals had many targets. The top five 
chemicals ranked by nc for each chemical category are summarized in Table S4. Most 
notably, we identified discriminative hub chemicals for each chemical category. For 
example, the highest node degree chemicals were endosulfan, TCDD, BaP, DDE, 
PFOA, copper, acetaminophen, and fluorouracil in the POPs, dioxins, PAHs, pesticides, 
PFCs, metals, PPCPs, and FDA-approved drugs categories, respectively (Fig. 2a and 
Table S4). The fat-tailed degree distributions for chemical-target nodes (Fig. 2b) 
indicated that most genes were targeted by a few chemicals; however, a few genes were 
targeted by many chemicals. The top five chemical targets ranked by ng for each 
chemical category are summarized in Table S5. The hub target proteins tended to be 
common among the chemical categories; for example, sex hormone receptors (e.g., 
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androgen receptor [AR] and estrogen receptors [ERs]) were targeted by a number of 
chemicals in different chemical categories.  
Chemical targets in the human protein–protein interaction network 
We examined the global relationships between chemical targets in the human PPI 
network and identified 231, 208, 276, 1000, 144, 79, 281, 1783, 2212, and 1061 
chemical-target proteins in the PPI networks for POPs, dioxins, PAHs, pesticide, PFCs, 
metals, PPCPs, and FDA-approved drugs categories, respectively (Fig. S1). For 
comparison, the node degrees of any and essential proteins were also considered (Fig. 
3). We then investigated the node degree (i.e., the number of interacting partners) in the 
PPI network for each chemical category (Fig. 3) and found that the chemical-target 
proteins had more interacting partners than any and essential proteins did. The median 
node degrees of the chemical targets were 76.8%–382.9% larger than that of any 
proteins in the PPI network (p < 10–8 using the Wilcoxon rank-sum test); moreover, the 
median node degrees of the chemical targets were higher than that the essential proteins 
(p < 10–6 using the Wilcoxon rank-sum test). Furthermore, we investigated the other 
nodal measures, closeness centrality, betweenness centrality, and clustering coefficients, 
and found similar trends in the degree centrality (Fig. S2). In particular, the proteins that 
were targeted by chemicals, including those encoded by essential genes (ESGs), had 
higher median closeness centrality than any proteins did (Fig. S2a; p < 10–4 using the 
Wilcoxon rank-sum test). Moreover, the centralities of POPs, dioxins, PAHs, pesticides, 
and multiple targeted proteins were higher than that of ESGs (Fig. S2a; p < 10–5 using 
the Wilcoxon rank-sum test). The median betweenness centrality of chemical targets 
was significantly higher than that of any proteins and ESGs (Fig. S2b; p < 10–5 with the 
Wilcoxon rank-sum test). POPs, dioxins, PAHs, pesticides and multiple targeted 
proteins showed a higher clustering coefficient than that of all proteins and ESGs (Fig. 
S2c; p < 10–5 using the Wilcoxon rank-sum test). These results suggest that contaminant 
targets are hub proteins and have a major effect on the human interactome.  
Chemical targets and gene essentiality 
The node degree is positively correlated with gene essentiality in the human PPI 
network (Jeong et al., 2001). Since the chemical targets had numerous interacting 
partners in the PPI network (Fig. 3), we hypothesized that chemical targets would be 
enriched in essential protein datasets. The association analysis showed that the PAHs, 
metals, and FDA-approved drug targets were enriched in human essential proteins; 
however, no positive associations were observed between the chemical targets in the 
other categories and essential genes. Instead, POPs, dioxins, and multiple targets were 
depleted with respect to essential genes (Fig. 4). These results suggest that chemical-
target proteins did not necessarily represent an abundance of essential genes, although 
they had larger interactions than essential genes did. 
Cellular network-based evaluation of effects of chemical targets on human 
diseases 
We investigated the relationship (distance) between chemical targets and disease-
associated proteins in the human PPI network to evaluate how chemicals in each 
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specific chemical category would directly affect human diseases. From the dataset of 
chemical-disease associations, we extracted chemical targets and disease-associated 
proteins from the PPI network and obtained 65,941 chemical-disease associations. We 
identified a remarkable enrichment in all chemical categories compared with the 
random controls at shorter than longer distance regions (Fig. 5). In all chemical 
categories, the distribution of the distance between the actual data and random controls 
was significantly different (Fig. 5; p < 0.01 using the KS test). Therefore, the distances 
between disease-associated and chemical-target proteins were shorter than those of the 
random control, suggesting the direct effects of these chemicals on human diseases.  
To further investigate the effect of these chemicals on human diseases, we focused on 
14 disease categories and compared the distance between the chemical targets and 
disease-associated proteins for each chemical category (Figs. 6, S3, and Table S6). Most 
disease categories had negative log2 values, which indicated that the chemical target 
and disease-associated proteins were more closely located than they were in the random 
control in the PPI network. A small log2 ratio indicated direct effects of the chemicals 
on human diseases. Specifically, all chemical categories directly influenced cancer and 
digestive system disease including colonic neoplasms, fatty liver, and hepatitis. 
However, the effect of chemicals on human diseases occasionally differed between the 
chemical categories. For example, POPs, dioxins, metals, PPCPs, and FDA-approved 
drugs had direct effects on endocrine system disease, immune system disease, nervous 
system disease, and respiratory tract disease categories, whereas dioxins indirectly 
affected diseases in the mental disorder category. Most distances between PFCs targets 
and disease-associated proteins were similar to the random control, which suggests that 
chemicals in the PFCs category indirectly affected human diseases. Similarly, PAHs 
indirectly affected proteins in the endocrine system disease, immune system disease, and 
nervous system disease categories. Pesticides indirectly affected immune system 
disease, nervous system disease, respiratory tract disease, and signs and symptoms 
(e.g., fever, headache, and chills). 
4. Discussion 
In this study, we focused on environmental contaminants and evaluated their effects on 
the human interactome and diseases using network biology techniques. We investigated 
the chemical-target network and found that the degree of chemical distributions and 
their targets were fat-tailed (Fig. 2). Similar distributions were also observed in the 
drug-target network described in this (Fig. 2 “approved drugs”) and previous (Yıldırım 
et al., 2007) studies. Yıldırım et al. (2007) investigated the drug-target network formed 
by interactions between FDA-approved drugs and their target proteins and demonstrated 
that most drugs targeted only a few proteins. The contaminant-target network also 
suggested that most genes were targeted by a few chemicals, while a few genes were 
targeted by many chemicals. The node degree of chemicals in the chemical-target 
network could reflect their ecotoxicological significance. For example, TCDD and BaP 
were significant hubs in the network (Fig. 2a). Historically, these chemicals have been 
used as representative substances of their chemical class for exposure experiments 
(Fracchiolla et al., 2016; Kim et al., 2013). 
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The proteins targeted by chemicals in different categories might have important roles in 
evaluating the combined effects of environmental pollutants. For example, the AR and 
ERs were conserved hub genes among the POPs, dioxins, PAHs, and pesticides 
categories, despite the differences in their chemical properties. Indeed, ERs are widely 
used to evaluate combined or mixed effects of xenoestrogens (e.g., POPs, dioxins, 
PAHs, and pesticides) such as endocrine disruption (Silins and Högberg, 2011). 
Moreover, the node degree of chemical targets is useful in identifying biomarkers of 
chemical exposure. For example, aryl hydrocarbon receptor (AHR), cytochrome P450 
1A1 (CYP1A1), and CYP1A2 were hub proteins in the dioxins and PAHs categories 
(Fig. 2b and Table S5). CYP1A1 is a widely used biomarker of the exposure of 
contaminants that bind to the AHR (Petrulis et al., 2001). Pregnane X receptor (PXR), 
CYP3A4, and CYP2B6 were hub targets in the pesticide category, which is consistent 
with the activation of PXR by organochlorine pesticides that induces the transcription of 
CYP3A4 and CYP2B6 (Bertilsson et al., 1998; Coumoul et al., 2002). Similarly, 
peroxisome proliferator-activated receptor α (PPARα) and PPARγ were hub targets in 
PFCs, and are activated by PCFs (Abbott, 2009; Rosen et al., 2017; Wolf et al., 2014). 
Chemokine (C-X-C motif) ligand 8 (CXCL8), tumor necrosis factor (TNF), and 
caspase-3 (CASP3) were hub proteins in the metal category. These proteins are reported 
as targets for metals (Carter et al., 1997; Khan et al., 2011; Kim et al., 2008), and they 
play important roles in tumor progression (Hamed et al., 2012; Knüpfer and Preiß, 
2007). Because AR and poly (ADP-ribose) polymerase 1 (PARP1), which is associated 
with DNA repair and cellular differentiation (Tao et al., 2009; Vinggaard et al., 2000), 
were hub targets in the PAH category, we hypothesized that AR and PARP1 are 
important biomarkers for PAHs. However, as their roles in toxicity are not well 
described, further examination is needed to verify this hypothesis.  
The contaminant target proteins had more interacting partners than any other proteins in 
the human PPI network did (Fig. 3). This trend was also observed for drug targets 
(Yıldırım et al., 2007). These results indicate that contaminant targets are hub proteins 
with a major effect on the human interactome because hubs are related to network 
robustness. Cancer treatments could be interpreted as targeted attacks on hub proteins 
such as p53 (Lane et al., 2010), and the fragility of networks is determined by these 
targeted attacks on hubs (Albert et al., 2000). Thus, the node degree of a chemical target 
in the PPI networks may be useful in estimating the effect of a chemical on the human 
interactome. In this context, other nodal measurements such as centrality measures may 
also be informative parameters to estimate the effect of chemicals on the human 
interactome. The analyses based on closeness centrality (Fig. S2a) and betweenness 
centrality (Fig. S2b) showed that the contaminant target proteins were more centric than 
any of the proteins in the human PPI network were. Closeness centrality was used to 
measure how fast the flow of information would be through a specific node to other 
nodes. Thus, this result suggests that chemical stimuli such as POPs, dioxins, PAHs, 
pesticides, and multiple protein categories rapidly spread in the human interactome 
compared to other chemicals such as PFCs and metals. A high betweenness centrality 
relies on communication paths and could control information flow; therefore, our results 
also indicate that pollutants and drugs considerably affect the human interactome. In 
this study, we found that the contaminant target proteins were more clustered than any 
proteins in the human PPI network were (Fig S2). The clustering coefficient of a node 
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(protein) characterizes the edge density among node neighbors and, thus, it is useful for 
identifying protein complexes. POPs-, dioxins-, PAHs-, pesticides- and multiple-
targeted proteins have tightly clustered interactions, and are expected to form large 
complexes. 
Association analyses between target proteins and essential proteins (Fig. 3) could be 
useful for estimating the effect of chemicals on humans, which are difficult to evaluate. 
POP, dioxins, and pesticide targets have many interacting partners; however, essential 
human proteins were not abundant among these targets (Fig. 4). This indicated that 
these target proteins have many interactions but are not essential for life. In contrast, the 
PAH, metal, and FDA-approved drug targets had a high node degree, and essential 
proteins were abundant among their targets, which indicates that these chemicals might 
have more severe effects on organisms than the other chemical categories do. PPCPs are 
also FDA-approved drugs; thus, they are expected to have the same interaction patterns 
as other FDA-approved drugs. However, unlike FDA-approved drug targets, PPCP 
targets were not abundant in essential protein categories. Therefore, we would expect 
PPCPs to have broad effects on the human interactome and lower lethality than FDA-
approved drugs. 
The distance between the chemical targets and disease-associated proteins estimates the 
number of molecular steps between a chemical target and the corresponding disease-
associated protein in the PPI network (Yıldırım et al., 2007). A shorter distance between 
chemical targets and disease-associated proteins indicates that the chemicals exert a 
more direct effect on diseases than a longer distance does. The network-based 
evaluation of these associations is useful for quantifying the effect of chemicals on 
human disease. Yıldırım et al. (2007) demonstrated that FDA-approved drugs had a 
higher enrichment of proteins in the region of the lower distances than the random 
control did. A high enrichment in the lower distances was also observed in this study 
(Fig. 5). Moreover, the distribution of the distances of all the contaminant categories 
showed clear enrichments at shorter distances similar to the previous study (Fig. 5) 
(Yıldırım et al., 2007). These results indicate that environmental contaminants are likely 
direct causes of human diseases. 
Finally, we evaluated the effect of chemical targets on a specific disease group (Fig. 6 
and Table S6) and found that most contaminants directly affected human diseases. 
Cancer and digestive system disease, including liver disease, were directly affected by 
all environmental contaminant and chemical drug categories (Fig. 6). This result is 
supported by a large body of evidence collected on the relationship between the 
exposure to these contaminants and the elevated risk of cancer development (Bahadar et 
al., 2014; Grandjean and Clapp, 2014; Kim et al., 2013; Tavakoly Sany et al., 2015; 
Tchounwou et al., 2012). For example, the International Agency for Research on 
Cancer (IARC) has reported that BaP, TCDD, and metal compounds should be 
classified as category one human carcinogens (IARC, 2010). The liver is prone to 
xenobiotic-induced injury because it plays an important role in xenobiotic metabolism 
(Sturgill and Lambert, 1997); and POPs mixtures, PAHs, pesticides, PFCs, and metals 
are known to have negative effects on liver health in humans and experimental animals 
(Carlin et al., 2016; Deierlein et al., 2017; Lindstrom et al., 2011; Min et al., 2015; 
VoPham et al., 2017). 
 
POPs, dioxins, pesticides, and metals had direct effects on members of the endocrine 
system disease category (Fig. 6). This may be because these environmental 
contaminants include major endocrine disrupting chemicals that perturb the normal 
synthesis, secretion, transportation, binding, and metabolism of natural hormones 
(Annamalai and Namasivayam, 2015). Generally, endocrine disruptors can exert their 
effects via two pathways: either directly on hormone-receptor complexes or directly on 
the specific proteins involved in the control of hormone delivery to the right place at the 
right time (WHO and UNEP, 2013). Since PAHs and PFCs showed indirect effects on 
the endocrine system disease category in this study (Fig. 6), the reported effects of these 
chemicals on components of the endocrine system could be induced by hormone-related 
proteins. 
POPs, dioxins, and metals directly affected the immune system disease group (Fig. 6 
and Table S6). In fact, chemicals in these categories are known to induce 
immunological disorders (Colborn et al., 1993; Gascon et al., 2013; Tchounwou et al., 
2012). In particular, AHR, a dioxin receptor, modulates the immune system through 
regulatory T-cell (Treg) expansion (Tavakoly Sany et al., 2015; Veldhoen et al., 2008). 
This is consistent with the lowest log2 ratio calculated for the dioxin category in the 
immune system disease group. In contrast, the effects of PAHs, pesticides, and PFCs on 
the immune system disease group were indirect, as the immunotoxic effects of PAHs are 
not directly caused by the parent compounds (Abdel-Shafy and Mansour, 2016). 
Moreover, epidemiological studies have shown the low immunotoxic risk of pesticides 
and PFOA (a type of PFC) (Corsini et al., 2013; Steenland et al., 2010). Although these 
epidemiological studies support our findings, experimental studies indicate a direct 
association between immune system disorders and pesticides/PFOA (Corsini et al., 
2013; Steenland et al., 2010). Further investigations would be required to clarify the 
effects of pesticides and PFCs on the human immune system. 
In addition to the general toxicities of PFCs (Grandjean and Clapp, 2014), our results 
suggest a direct effect of PFCs on nervous system diseases. This result is consistent 
with the negative association between blood PFC levels and impulsivity/short-term 
memory impairment observed in children (Gallo et al., 2013; Gump et al., 2011). 
Furthermore, increased PFOA concentrations were associated with elevated cholesterol 
and uric acid levels in humans, which may cause cerebrovascular diseases (Miralles-
Marco and Harrad, 2015) that are categorized in the nervous system disease group. The 
chemical-target network analysis showed that PFCs were related to PPARα and PPARγ 
(Fig. 2b). PFCs possibly cause cerebrovascular diseases through PPARs and, therefore, 
the PPAR family (α, γ, and β/δ) could be a therapeutic target for cerebrovascular 
diseases (Nicolakakis and Hamel, 2010).  
Previous studies suggest that pesticide exposure can increase the risk of nervous system 
diseases such as Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS) in 
humans (Nandipati and Litvan, 2016; Sánchez-Santed et al., 2016). However, in this 
study, we did not find a direct effect of pesticides on the nervous system disease 
category (Fig. 6). This may have been because many pesticides indirectly contribute to 
nervous system diseases (Nandipati and Litvan, 2016), but some pesticides such as 
organochlorine pesticides, could directly contribute to nervous system disease 
development (Sánchez-Santed et al., 2016). 
 
Our analysis identified a significant direct effect of PAHs but not pesticides and PFCs 
on respiratory tract disease. This was supported by several pieces of evidence, 
including those suggesting that PAHs are formed mainly by organic fuel combustion 
and released into the atmosphere (Baek et al., 1991), where they can contribute to risk 
factors for respiratory cancer and childhood asthma (Bosetti et al., 2007; Karimi et al., 
2015; Rota et al., 2014). A meta-analysis study concluded that the relationship between 
pesticide exposure and respiratory health is controversial (Mamane et al., 2015), and 
several other studies suggest that occupational exposure to pesticides increases the risks 
of developing asthma (Fareed et al., 2013; Ye et al., 2013). However, there is little 
epidemiological evidence to support the relationship between PFC exposure and asthma 
in humans (Dong et al., 2013), although a study in mice indicated a possible association 
(Fairley et al., 2007). 
Our analysis suggests that PPCPs directly affect mental disorders, nervous system 
diseases, and signs and symptoms such as fever, headache and chills, heart murmurs, 
and motion sickness. Indeed, the PPCPs category includes antidepressants such as 
sertraline, fluoxetine, and amitriptyline, which are used for the treatment of nervous 
system diseases and mental disorders, and antipyretic analgesics such as acetaminophen 
and ibuprofen for the treatment of fever and headache. Currently, the human health risk 
from exposure to PPCPs has indicated little cause for concern; however, the effect of 
PPCPs on human health may be significant in the future because of the combination of 
increased PPCP use and potential drought increase PPCP concentrations in wastewaters 
over the next few decades (Cizmas et al., 2015). 
While our results provide new data in evaluating the effect of environmental 
contaminants on human PPI and diseases, it is important to also understand the 
limitations of the methodology. First, the effective concentrations and adverse outcomes 
of chemicals depend on the route of exposure (Damalas and Eleftherohorinos, 2011); 
however, data on the route of exposure was not available at the time of our study. 
Second, we selected chemicals that have been linked to gene expression changes, 
human health risks, and have suggested exposure risks to humans. Thus, chemical 
compounds that have no information on related genes, adverse outcome/disease, or 
exposure status were excluded from our analysis. Third, we evaluated the relationship 
between environmental contaminants and human diseases, although the cumulative risk 
of chemical mixtures was not investigated. To avoid these limitations in the future, 
larger-scale and more normalized databases should be constructed through data sharing. 
In addition to these experimental considerations, additional quantitative approaches 
could improve the prospective mixture risk assessment. Nonetheless, our findings 
provide a novel tool for identifying biomarkers to evaluate toxic effects of several 
chemical categories and evaluating the strength of relationships between relevant 
environmental contaminants and human diseases. 
5. Conclusions 
We quantitatively evaluated the effect of environmental contaminants on the human 
interactome and diseases using a network biology-based approach. The chemical-target 
network identified proteins with important roles in the human interactome and its 
sensitivity to multiple chemicals. Although chemical-target proteins had more 
 
interacting partners than essential genes did, they do not necessarily represent an 
abundance of essential genes. Our analyses suggest that environmental contaminants 
may directly affect disease-associated proteins and, consequently, cause specific 
diseases. However, the degree of the effect of each environmental contaminant on 
human diseases depends on the disease type and chemical category. Epidemiological 
and experimental evidence support our findings, and the methods we used could 
enhance our understanding of the relationship between environmental exposure and 
adverse human health outcomes.  
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Figure legends 
Figure 1. Partial chemical-target network. Circles and rectangles correspond to 
chemicals (environmental contaminants) and target proteins, respectively. Network was 
extracted from the whole chemical-target network by selecting nodes with a degree > 
20. Node size indicates node degree. Chemical nodes (circles) are colored according to 
chemical categories. Network layout (e.g., position of nodes and lengths of edges) is 
based on the prefuse force directed layout algorithm in Cytoscape (version 3.5.1). 
Abbreviations of chemicals represented here are: BDE49, 2,2′,4,5′-tetrabromodiphenyl 
ether; HBCD, hexabromocyclododecane; NiSO4, nickel(II) sulfate. Abbreviations for 
genes are; BCL2, B-cell lymphoma 2; CAT, Catalase; HIF1A, hypoxia-inducible factor 
1 alpha; HMOX1, heme oxygenase 1; IL, interleukin; MAPK, mitogen-activated protein 
kinase; NR1I3, nuclear receptor subfamily 1 group I member 3; PGR, progesterone 
receptor; PTGS2, prostaglandin-endoperoxide synthase; RELA, transcription factor 
p65. 
 
Figure 2. Degree distributions of chemical-target networks. Distribution of number of 
(a) genes targeted by a chemical (nc) and (b) chemicals targeting a gene (ng). CAR, 
constitutive androstane receptor; PTPN11, protein tyrosine phosphatase, non-receptor 
type 11; SLC22A2 and SLC22A11, solute carrier family 22 member 2 and member 11. 
Figure 3. Boxplot of node degree [log2(degree)] of chemical targets in human protein–
protein interactions (PPI) network of each chemical category. See Sec. 2 for details of 
chemical categories. Proteins in the multiple category are targeted by chemical(s) in 
multiple chemical categories. Node degrees of any (all) and essential proteins (ESGs) 
also displayed for comparison; p-value, using Wilcoxon rank-sum test.  
Figure 4. Ratio of essential proteins to target proteins for each chemical category. See 
Figure 3 for category definitions; p-value, using Fisher’s exact test. 
Figure 5. Distribution of distances between chemical targets and disease-associated 
proteins (red). Distribution of random controls (i.e., distances between randomly 
selected and disease-associated proteins) also shown (blue); p-value, using the 
Kolmogorov-Smirnov (KS) test.  
Figure 6. Difference in mean distance between actual data (Dreal) and random control 
(Drand) values evaluated using Welch’s two-sample t-test. 
 
Figure S1. Partial human protein–protein interaction network. Only targets of dioxins 
and disease-associated proteins are presented. Node size corresponds to node degree. 
Rectangular nodes indicate chemical (dioxins) targets; circle nodes indicate genes not 
targeted by chemical (dioxins). Nodes are colored based on related disease classes. 
Rectangle nodes with red edge indicate that proteins are both chemical targets and 
disease-associated. 
Figure S2. Boxplots for centrality indicators of chemical targets (proteins) in human 
protein–protein interactions (PPI) network according to chemical categories. (a) 
Betweenness centrality [log2(betweenness)], (b) closeness centrality [log2(closeness)], 
and (c) clustering coefficient centrality [log2(clustering coefficient)] were calculated for 
each node. See Figure 3 for category definitions; p-value, using Wilcoxon rank-sum 
test. ESGs, essential proteins. 
 
Figure S3. Difference in mean distance between actual data (Dreal) and a random 
control (Drand) for 14 disease categories; p-value, using Welch’s two-sample t-test. 
 
Table S1. List of nodes for human protein–protein interactions (PPI). Each row 
indicates interaction pair. 
Table S2. Chemicals and corresponding categories, and target genes obtained from 
Comparative Toxicogenomics Database (CTD, as of July 06, 2017). Numbers (0/1) 
indicate whether chemical belongs to category (1) or not (0). 
Table S3. Network properties of nodes in chemical-target network 
Table S4. List of top five hub chemicals in chemical-target network  
Values in brackets indicate number of genes targeted by the chemical.  
 
Table S5. List of top five hub target proteins in chemical-target network  
Values in brackets indicate number of chemicals targeting the gene. 
 
Table S6. List of p-values of differences between Dreal and Drand 
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